Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Helicobacter Pylori Eradication

Effectiveness of Clarithromycin Based and Levofloxacin Based Quadruple Therapy in Combination with Atorvastatin for Helicobacter Pylori Eradication

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200929048884N1

Enrollment

200

Registered

2020-10-05

Start date

2020-10-11

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere

Interventions

Intervention 1: Intervention group: Pentoprazole 40 tablet, Octover company, orally, twice a day + Atorvastatin 40 tablet, orally, once a day + Bismuth 500 tablet, orally, four times a day + Amoxicil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Aged between 18-75 Need to Helicobacter pylori eradicate

Exclusion criteria

Exclusion criteria: Receive previous treatment to eradicate Helicobacter pylori History of allergies to the drugs used in the study

Design outcomes

Primary

Measure	Time frame
Helicobacter pylori eradication. Timepoint: One month after the end of treatment. Method of measurement: Stool antigen test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Khodadadi

Ghoum University of Medical Sciences

jkhodadadi@muq.ac.ir+98 25 3261 7638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026